The National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2007: reform or fracture?

Ken J Harvey, Anthony H Harris and Liliana Bulfone
Med J Aust 2007; 187 (4): . || doi: 10.5694/j.1326-5377.2007.tb01199.x
Published online: 20 August 2007

Reform is needed, but will the current Bill enact the best options?

Two articles in this issue of the Journal1,2 comment on a complex but important piece of legislation put forward by the Minister for Health and Ageing — the National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2007 (the Bill).3

  • Ken J Harvey1
  • Anthony H Harris2
  • Liliana Bulfone2

  • 1 School of Public Health, La Trobe University, Melbourne, VIC.
  • 2 Centre for Health Economics, Monash University, Melbourne, VIC.


Competing interests:

Ken Harvey is a member of the Australian Labor Party (ALP) and the ALP candidate for Kooyong in the forthcoming federal election. Anthony Harris and Liliana Bulfone are part of a group at Monash University providing commentaries to the Australian Government on submissions to the Pharmaceutical Benefits Advisory Committee.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.